Meeting
2024 ASCO Genitourinary Cancers Symposium
Relugolix versus leuprolide in combination with radiotherapy for localized prostate cancer (REVELUTION trial): An initial analysis of patient treatment preferences and quality of life.
Authors
Sagar A. Patel
Emory University, Atlanta, GA
Sagar A. Patel , Subir Goyal , Yuan Liu , Bruce W. Hershatter , Pretesh R. Patel , Vishal Ramesh Dhere , Nikhil Sebastian , Ashesh B. Jani , Anant Mandawat
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Clinical Trial Registration Number
NCT 05320406
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 301)
DOI
10.1200/JCO.2024.42.4_suppl.301
Abstract #
301
Poster Bd #
M14
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
NRG-GU011: A phase II double-blinded, placebo-controlled trial of prostate oligometastatic radiotherapy with or without androgen deprivation therapy in oligometastatic prostate cancer (NRG PROMETHEAN).
First Author: Bridget F. Koontz
Poster
2020 Genitourinary Cancers Symposium
Late toxicity and quality of life from GETUG-AFU 22 study.
First Author: Igor Latorzeff
Poster
2018 Genitourinary Cancers Symposium
Self-reported burden in patients with localized prostate cancer treated with stereotactic body radiation therapy (SBRT).
First Author: Abigail Pepin
Poster
2024 ASCO Genitourinary Cancers Symposium
Weight variation during androgen deprivation therapy in patients with localized prostate cancer: Data from two prospective randomized trials.
First Author: Abdenour Nabid